RTA Laboratuvarlari Biyolojik (RTALB) — Capital Reinvestment Ratio
RTA Laboratuvarlari Biyolojik (RTALB) has a Capital Reinvestment Ratio of 0.13x as of June 2025, meaning it reinvests 0% of its operating cash flow (TL20.98 Million) in capital expenditures (TL2.68 Million). See cash generation quality of RTA Laboratuvarlari Biyolojik to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
RTA Laboratuvarlari Biyolojik Capital Reinvestment Ratio (2010–2023)
This chart tracks RTA Laboratuvarlari Biyolojik's Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for RTA Laboratuvarlari Biyolojik (2010–2023)
Year-by-year Capital Reinvestment Ratio for RTA Laboratuvarlari Biyolojik from 2010 to 2023. For live market cap and broader valuation context, see market value of RTA Laboratuvarlari Biyolojik.
| Year | Reinvestment Ratio | Operating CF (TRY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.67x | TL72.41 Million | TL48.48 Million | ▲ +114.8% |
| 2021 | 0.31x | TL68.78 Million | TL21.43 Million | ▼ -81.7% |
| 2020 | 1.70x | TL9.37 Million | TL15.96 Million | ▲ +17.4% |
| 2019 | 1.45x | TL3.58 Million | TL5.19 Million | ▲ +540.2% |
| 2017 | 0.23x | TL1.41 Million | TL318.64K | ▼ -73.2% |
| 2016 | 0.85x | TL2.86 Million | TL2.42 Million | ▲ +213.5% |
| 2015 | 0.27x | TL6.18 Million | TL1.67 Million | ▲ +9.1% |
| 2014 | 0.25x | TL2.58 Million | TL640.00K | ▼ -70.8% |
| 2013 | 0.85x | TL11.26 Million | TL9.56 Million | ▼ -9.3% |
| 2012 | 0.94x | TL2.24 Million | TL2.09 Million | ▲ +349.9% |
| 2011 | 0.21x | TL1.61 Million | TL335.00K | ▲ +6.7% |
| 2010 | 0.19x | TL2.78 Million | TL541.00K | — |